ES2180922T3 - Comprimidos de alto contenido en famciclovir. - Google Patents

Comprimidos de alto contenido en famciclovir.

Info

Publication number
ES2180922T3
ES2180922T3 ES97901539T ES97901539T ES2180922T3 ES 2180922 T3 ES2180922 T3 ES 2180922T3 ES 97901539 T ES97901539 T ES 97901539T ES 97901539 T ES97901539 T ES 97901539T ES 2180922 T3 ES2180922 T3 ES 2180922T3
Authority
ES
Spain
Prior art keywords
famciclovir
high content
content tablets
tablets
percentage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97901539T
Other languages
English (en)
Spanish (es)
Inventor
Michael John Greenway
Jennifer Mary Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of ES2180922T3 publication Critical patent/ES2180922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES97901539T 1996-01-16 1997-01-13 Comprimidos de alto contenido en famciclovir. Expired - Lifetime ES2180922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2180922T3 true ES2180922T3 (es) 2003-02-16

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97901539T Expired - Lifetime ES2180922T3 (es) 1996-01-16 1997-01-13 Comprimidos de alto contenido en famciclovir.

Country Status (37)

Country Link
US (1) US6765007B1 (2)
EP (1) EP0874632B1 (2)
JP (2) JP4711360B2 (2)
KR (1) KR100338829B1 (2)
CN (1) CN1132582C (2)
AP (2) AP747A (2)
AR (1) AR005456A1 (2)
AT (1) ATE220910T1 (2)
AU (1) AU713090B2 (2)
BG (1) BG63488B1 (2)
BR (1) BR9706982A (2)
CY (1) CY2390B1 (2)
CZ (1) CZ287205B6 (2)
DE (1) DE69714215T2 (2)
DK (1) DK0874632T3 (2)
DZ (1) DZ2159A1 (2)
EA (1) EA001946B1 (2)
EG (1) EG23684A (2)
ES (1) ES2180922T3 (2)
GB (1) GB9600847D0 (2)
HU (1) HU225472B1 (2)
IL (1) IL124913A0 (2)
MX (1) MX9805713A (2)
MY (1) MY127527A (2)
NO (1) NO315689B1 (2)
NZ (1) NZ326769A (2)
OA (1) OA10812A (2)
PE (1) PE35498A1 (2)
PL (1) PL187291B1 (2)
PT (1) PT874632E (2)
SK (1) SK282132B6 (2)
TR (1) TR199800954T2 (2)
TW (1) TW434016B (2)
UA (1) UA63897C2 (2)
UY (2) UY24437A1 (2)
WO (1) WO1997025990A1 (2)
ZA (1) ZA97310B (2)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
EP0182024B1 (en) 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
HUT67392A (en) 1991-05-15 1995-04-28 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
DK0874632T3 (da) 2002-11-11
GB9600847D0 (en) 1996-03-20
MY127527A (en) 2006-12-29
PE35498A1 (es) 1998-08-07
AU713090B2 (en) 1999-11-25
AP1114A (en) 2002-10-18
SK95698A3 (en) 1999-01-11
BG63488B1 (bg) 2002-03-29
CZ225498A3 (cs) 1998-12-16
CZ287205B6 (en) 2000-10-11
PL327922A1 (en) 1999-01-04
MX9805713A (es) 1998-10-31
AP9801298A0 (en) 1998-09-30
JP2009091362A (ja) 2009-04-30
OA10812A (en) 2003-01-29
EA199800573A1 (ru) 1999-02-25
ZA97310B (en) 1997-10-23
DE69714215T2 (de) 2003-01-23
CY2390B1 (en) 2004-09-10
KR100338829B1 (ko) 2002-07-18
PT874632E (pt) 2002-10-31
HU225472B1 (en) 2006-12-28
EP0874632A1 (en) 1998-11-04
UY24437A1 (es) 1997-06-06
IL124913A0 (en) 1999-01-26
NO983259L (no) 1998-07-15
BG102638A (bg) 1999-07-30
PL187291B1 (pl) 2004-06-30
UA63897C2 (en) 2004-02-16
AP747A (en) 1999-05-03
AP9700911A0 (en) 1997-01-31
AR005456A1 (es) 1999-06-23
UY24556A1 (es) 2001-08-27
HK1016473A1 (en) 1999-11-05
DZ2159A1 (fr) 2002-12-01
ATE220910T1 (de) 2002-08-15
EP0874632B1 (en) 2002-07-24
NO983259D0 (no) 1998-07-15
HUP9901021A3 (en) 2000-08-28
TW434016B (en) 2001-05-16
NO315689B1 (no) 2003-10-13
SK282132B6 (sk) 2001-11-06
TR199800954T2 (xx) 1998-10-21
HUP9901021A2 (hu) 1999-08-30
EG23684A (en) 2007-05-09
NZ326769A (en) 2000-05-26
WO1997025990A1 (en) 1997-07-24
CN1132582C (zh) 2003-12-31
CN1208350A (zh) 1999-02-17
BR9706982A (pt) 1999-07-20
DE69714215D1 (de) 2002-08-29
US6765007B1 (en) 2004-07-20
EA001946B1 (ru) 2001-10-22
AU1541897A (en) 1997-08-11
JP4711360B2 (ja) 2011-06-29
JP2000503311A (ja) 2000-03-21
KR19990077229A (ko) 1999-10-25

Similar Documents

Publication Publication Date Title
MX9304967A (es) Tabletas de liberacion sostenida controlada.
ES2096103T3 (es) Preparacion de comprimidos de resistencia incrementada.
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
IL138767A0 (en) Anticancer compositions
NZ507271A (en) Fast disintegrating tablets
ATE177630T1 (de) Gegen missbrauch geschuetzte tabletten
DE68901417D1 (de) Pharmazeutische zusammensetzung.
BG103714A (en) Pararacetamol-containing tablet
ES2167609T3 (es) Formulaciones de quinolona inyectables.
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ATE254914T1 (de) Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
WO2005007137A3 (de) Ambroxolhaltige tabletten
ES2143180T3 (es) Composiciones farmaceuticas en forma de comprimidos de liberacion prolongada a base de granulados de polisacaridos de elevado peso molecular.
ATE128363T1 (de) Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
ES2180922T3 (es) Comprimidos de alto contenido en famciclovir.
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
DK0427124T3 (da) Antacidatabletter
NO943070L (no) Antitussiva
MXPA04003851A (es) Antipruriticos.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
BR0212195A (pt) Composições contendo pectina e ácido ascórbico
ATE201996T1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen
ATE269061T1 (de) Calciumhaltige brausetablette mit einem antihistaminikum als wirkstoff
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung